These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 20620173)
1. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP. Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173 [TBL] [Abstract][Full Text] [Related]
2. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Zhang D; Brodt P Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384 [TBL] [Abstract][Full Text] [Related]
3. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739 [TBL] [Abstract][Full Text] [Related]
4. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Sroka IC; Nagle RB; Bowden GT Neoplasia; 2007 May; 9(5):406-17. PubMed ID: 17534446 [TBL] [Abstract][Full Text] [Related]
5. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related]
6. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway. Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814 [TBL] [Abstract][Full Text] [Related]
7. Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration. Sabbota AL; Kim HR; Zhe X; Fridman R; Bonfil RD; Cher ML Cancer Res; 2010 Jul; 70(13):5558-66. PubMed ID: 20551048 [TBL] [Abstract][Full Text] [Related]
8. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis. Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045 [TBL] [Abstract][Full Text] [Related]
9. Limited processing of pro-matrix metalloprotease-2 (gelatinase A) overexpressed by transfection in PC-3 human prostate tumor cells: association with restricted cell surface localization of membrane-type matrix metalloproteinase-1. Wilson MJ; Jiang A; Wiehr C; Wang X; Sinha AA; Pei D J Androl; 2004; 25(2):274-85. PubMed ID: 14760014 [TBL] [Abstract][Full Text] [Related]
10. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Blando J; Portis M; Benavides F; Alexander A; Mills G; Dave B; Conti CJ; Kim J; Walker CL Am J Pathol; 2009 May; 174(5):1869-79. PubMed ID: 19395652 [TBL] [Abstract][Full Text] [Related]
11. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. Zhang D; Bar-Eli M; Meloche S; Brodt P J Biol Chem; 2004 May; 279(19):19683-90. PubMed ID: 14993222 [TBL] [Abstract][Full Text] [Related]
12. LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells. Tapia T; Ottman R; Chakrabarti R Mol Cancer; 2011 Jan; 10():6. PubMed ID: 21219645 [TBL] [Abstract][Full Text] [Related]
13. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis. Tan M; Xu J; Siddiqui J; Feng F; Sun Y Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654 [TBL] [Abstract][Full Text] [Related]
14. PDGF-BB-induced MT1-MMP expression regulates proliferation and invasion of mesenchymal stem cells in 3-dimensional collagen via MEK/ERK1/2 and PI3K/AKT signaling. Sun X; Gao X; Zhou L; Sun L; Lu C Cell Signal; 2013 May; 25(5):1279-87. PubMed ID: 23415772 [TBL] [Abstract][Full Text] [Related]
15. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways. Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963 [TBL] [Abstract][Full Text] [Related]
16. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation. Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017 [TBL] [Abstract][Full Text] [Related]
17. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. Choi YA; Lim HK; Kim JR; Lee CH; Kim YJ; Kang SS; Baek SH J Biol Chem; 2004 Aug; 279(35):36579-85. PubMed ID: 15220345 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth. Bonfil RD; Dong Z; Trindade Filho JC; Sabbota A; Osenkowski P; Nabha S; Yamamoto H; Chinni SR; Zhao H; Mobashery S; Vessella RL; Fridman R; Cher ML Am J Pathol; 2007 Jun; 170(6):2100-11. PubMed ID: 17525276 [TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells. Ling Poon S; Lau MT; Hammond GL; Leung PC Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435 [TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. Axanova LS; Chen YQ; McCoy T; Sui G; Cramer SD Prostate; 2010 Nov; 70(15):1658-71. PubMed ID: 20583132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]